•  
  •  
  •  
  •  

2025-12-24 19:28:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh
  • SJVN achieves COD of 1,000 MW Bikaner Solar Power Project in Rajasthan
  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • Moneyboxx Finance wins at 7th BW Emerging Business Awards 2025
  • Manaksia Coated Metals & Industries Undertakes Upgradation, Capacity Expansion for its Continuous Galvanizing Line

Keywords Selected:  ACE

Research

  • Crisil Ratings : Data centre operators' revenue to surge 20-22% annually till fiscal 2028
  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Elara Securities India - Diet Report - Ambuja Cements - Cash deployment starts
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Payback period for investment in sustainable warehouses come down to three years in India: A JLL - IndoSpace report
  • CRISIL Ratings: Mall area to rise by 35% over the medium term on retail surge
  • CRISIL Ratings: Higher workplace occupancy to light up cigarette volume 7-9%
  • Company Update - P&G Health - ICICI Direct
  • Profits on Housing Investment - Past, Present, and Future
  • Coworking Share in Office Real Estate at 20% in H1 2022 from 6% in 2021
  • Over 45 Data Centres Spanning ~13 Mn Sft to Boot Up in India by 2025-end
  • Why Commercial Real Estate Investors are betting on Office Spaces
  • ICRA's sample set of Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
  • Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct
  • UltraTech Cement - Cost escalations getting passed on QoQ - ICICI Securities
  • Ambuja Cements - 1QCY22 Result Update - Realization Falters, but Volume and EBITDA Beat
  • Ambuja Cement - Cost controls lift margin QoQ - HDFC Securities
  • Company Update - Mahindra Lifespace Developers - ICICI Direct
  • Ambuja Cements - Improved margins over sequential cost decline - YES Securities
  • Ambuja Cement - Q1CY22 Result Update - Beat on estimates; Clarity on Holcim's exit holds the key - Downgrade to 'HOLD'
  • Mahindra Lifespaces - Outperformance continues - HDFC Securities
  • Mahindra Lifespace Developers - Well poised for growth - ICICI Securities
  • Ambuja Cement - Q1CY22 First Cut - ICICI Direct
  • Ambuja Cements - 4QCY21 Result Update - Cost Pressure Led to EBITDA Miss

IPO News

  • SBI Funds, DSP India Fund, Think India Opportunities Fund invest Rs. 144 cr in Aequs Ltd. in pre-IPO placement deal
  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • IT Solutions major, Rashi Peripherals raised Rs 150 crore in Pre-IPO round
  • Awfis Space Solutions Limited files DRHP with SEBI
  • Jupiter Life Line Hospitals raised Rs123 cr in pre -IPO round
  • Penna Cement gets Sebi nod for Rs 1,550 crore IPO

Stock Report

  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Innovators Facade Systems Ltd receives LoA from Avante Spaces Limited
  • Zydus partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
  • Ajanta signs in-licensing agreement with Biocon for marketing Semaglutide in 26 countries
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • Ambuja Cements Ltd Board approves amalgamation of ACC Limited and Orient Cement Limited
  • CORONA Remedies Ltd commissions additional capacity
  • Shukra Pharmaceuticals Ltd receives authorization from Univlabs Technologies Pvt. Ltd.
  • Emcure expands weight management therapy access with Launch of Poviztra®
  • Granules Pharmaceuticals Inc. receives FDA tentative approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets
  • Ace Software Exports Ltd approves allotment 54,71,101 partly paid up rights shares
  • HCLTech recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for Data Center Outsourcing Services
  • Sai Life Sciences Releases Sustainability Report 2024-25
  • Pfizer & Cipla announce Exclusive Marketing and Distribution Partnership for Select Brands in India
  • Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
  • Lupin signs exclusive licensing agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
  • CFF Fluid Control Ltd receives order worth Rs. 5.31 crores
  • RattanIndia announces Partnership with the noon E-Commerce Marketplace to Launch E-Commerce Retailing in the Gulf Region
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004%
  • APL Healthcare Ltd's Unit-4 gets 5 observations from USFDA
  • US FDA determines Sun Pharma's Baska facility inspection classification as OAI
  • Mahindra Lifespaces launches Mahindra Blossom, a Net Zero Waste residential project in Whitefield, Bengaluru
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Datopotamab Deruxtecan powder

Industry News

  • Amansa Investment invests Rs 40 crore private placement in IPO bound Standard Glass Lining Technology
  • Millennium Babycares Ltd raises INR 1220 Million in Private Placement Round from Bharat Value Fund
  • VIKRAN Engineering Closes Pre-IPO Up-round of INR 100 Crores
  • Awfis expands in Bhubaneshwar with almost 1L sq ft space
  • Uber India is now Great Place To Work Certified
  • The Leela Palaces, Hotels and Resorts wins Best Hotel Group in India
  • The Leela Palaces, Hotels and Resorts announces its foray into Northeast India
  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India
  • As Offices are Reopening, Investing in commercial assets might be a lucrative deal
  • Want to save Construction cost? Follow these seven tips
  • SIDBI joins hands with UPEIDA to support MSMEs in Aerospace & Defence sector

Latest Post

  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh
  • SJVN achieves COD of 1,000 MW Bikaner Solar Power Project in Rajasthan
  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • Moneyboxx Finance wins at 7th BW Emerging Business Awards 2025
  • Manaksia Coated Metals & Industries Undertakes Upgradation, Capacity Expansion for its Continuous Galvanizing Line


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024